Endocytic uptake of a large array of HPMA copolymers: Elucidation into the dependence on the physicochemical characteristics

https://doi.org/10.1016/j.jconrel.2009.12.022Get rights and content

Abstract

Endocytic uptake and subcellular trafficking of a large array of HPMA (N-(2-hydroxypropyl)methacrylamide) based copolymers possessing positively or negatively charged residues, or hydrophobic groups were evaluated by flow cytometry and living cell confocal microscopy in cultured prostate cancer cells. The degrees of cellular uptake of various copolymer fractions with narrow polydispersities were quantified. The copolymer charge was the predominant physicochemical feature in terms of cellular uptake. Fast and efficient uptake occurred in positively charged copolymers due to non-specific adsorptive endocytosis, whereas slow uptake of negatively charged copolymers was observed. The uptake of copolymers was also molecular weight dependent. The copolymers were internalized into the cells through multiple endocytic pathways: positively charged copolymers robustly engaged clathrin-mediated endocytosis, macropinocytosis and dynamin-dependent endocytosis, while weakly negatively charged copolymers weakly employed these pathways; strongly negatively charged copolymers only mobilized macropinocytosis. HPMA copolymer possessing 4 mol% of moderately hydrophobic functional groups did not show preferential uptake. All copolymers ultimately localized in late endosomes/lysosomes via early endosomes; with varying kinetics among the copolymers. This study indicates that cell entry and subsequent intracellular trafficking of polymeric drug carriers are strongly dependent on the physicochemical characteristics of the nanocarrier, such as charge and molecular weight.

Graphical Abstract

Positively charged HPMA copolymer (P-DEMA20) was internalized faster and more efficiently than negatively charged copolymer (P-MAA20) by LNCaP C4-2 cells.

  1. Download : Download full-size image

Introduction

Employment of macromolecular drug carriers for the delivery of anticancer therapeutics has resulted in significant improvements in treatment efficacy [1]. A variety of macromolecular drug carriers are currently under investigation. An ideal macromolecular drug carrier should possess preferable pharmacokinetics, highly efficient cellular uptake and preferential subcelluar trafficking. These biological merits are determined to a large extent by physicochemical characteristics of the macromolecular drug carriers. For instance, molecular weight has an impact on the intravascular half-life and renal clearance [2]. Positively charged macromolecular drug carriers are internalized by cells more efficiently than negatively charged carriers, however their uptake occurs in the majority of cells [3]. Nevertheless, how the physicochemical characteristics of drug carriers determine their uptake and subcellular trafficking remains largely unknown.

Understanding the uptake and subcellular trafficking of macromolecular drug carriers by cells relies on knowledge of the complexity and diversity of endocytic pathways. Many endocytic pathways have been identified and a variety of classification schemes have been proposed. Based on the cargo, endocytosis is classified as phagocytosis or pinocytosis (fluid-phase endocytosis) [4]. Based on receptors, endocytosis can be designated as receptor mediated endocytosis specified by involvement of specific high-affinity receptors, adsorptive endocytosis denoted by nonspecific binding of solutes to the cell membrane, and regular endocytosis taking up surrounding fluid unspecifically [5]. Most common classification schemes of endocytosis are based on protein machinery that facilitates the process, such as clathrin-mediated endocytosis, and clathrin independent endocytosis [5], [6], [7], [8]. Clathrin independent endocytosis is further categorized as caveolae-mediated endocytosis and clathrin- and caveolin-independent endocytosis [5], [7] or dynamin-dependent and dynamin-dependent endocytosis [7], [8]. Dynamin is a GTPase protein that surrounds the neck of vesicle pits and facilitates the scission of many, but not all vesicles, such as clathrin-coated, caveolae-mediated and clathrin- and caveolin-independent vesicles [9]. Macropinocytosis is a distinct pathway of pinocytosis [5], [10], [11]; traditionally, macropinocytosis was designated as bulk non-selective and constitutive uptake of extracellular fluid through plasma membrane protrusion or ruffling. It has been recently recognized as an elaborately coordinated process including actin-mediated membrane reorganization and regulation of signaling, such as phosphoinositide (PI) 3-kinases [10], [11].

Hydrophilic and neutral copolymers of N-(2-hydroxypropyl)methacrylamide (HPMA) have been broadly used as linear water soluble polymeric drug carriers for therapeutic applications [12], [13]. Several drug-polymer conjugates based on HPMA copolymers have been studied clinically. A doxorubicin–HPMA copolymer conjugate PK1 was the first HPMA copolymer drug conjugate to enter clinical trials [14]. Phase II trial of PK1 in breast, non-small cell lung and colorectal cancers suggested that polymer-bound therapeutics are capable of improving anticancer activities [15]. PK2 [16], a compound related to PK1, and several HPMA copolymer drug conjugates containing taxol, camptothecin, and platinum entered Phase I clinical trials [17], [18], [19], [20]. HPMA copolymers are internalized into cells through endocytosis as shown in an early study on HPMA copolymers containing different degradable peptidyl side chains using rat visceral yolk sacs cultured in vitro [21]. Incorporation of hydrophobic tyrosinamide residues, bound either directly to the polymer main chain or through a glycylglycine linker, enhanced the uptake of HPMA copolymers [22]. More recently, endocytic uptake and subcellular trafficking of a HPMA antibody conjugate have been studied [23].

In the present study, the relationship between the mechanisms of endocytic uptake and subcellular trafficking of a large array of fluorescently-labeled, HPMA based copolymers and their physicochemical characteristics, such as charge, molecular weight and hydrophobicity, was studied. The array was composed of 9 HPMA copolymers with 5 comonomers possessing functional groups with positive or negative charges or containing a short hydrophobic peptide. FITC-labeled polyHPMA (P-FITC) was used as control. These copolymers were fractionated using size exclusion chromatography to create parallel Mw “ladders” consisting of 10 narrowly polydisperse fractions with molecular weights ranging from 10 to 200 kDa. Cellular uptake of the HPMA copolymer fractions and involvement of different endocytic pathways were assessed by flow cytometry in cultured prostate cancer cells. Subcellular trafficking of membrane vesicles carrying copolymers was characterized by living cell confocal microscopy.

Section snippets

Materials

All chemicals and solvents used were of reagent grade or better unless otherwise stated. The monomers, MAA (methacrylic acid), SEMA (2-sulfoethyl methacrylate), DEMA (2-(N,N-dimethylamino)ethyl methacrylate), and MATC (methacryloyloxyethyl trimethylammonium chloride) were purchased from PolySciences (Warrington, PA), Alexa Fluor 647-labeled dextran 10 kDa and Hoechst 33342 were purchased from Molecular Probes (Carlsbad, CA). Chlorpromazine, filipin complex, mevinolin, Dynasore, 5-(N-ethyl-N

Design and characterization of HPMA copolymers containing different functional groups

A large array of HPMA copolymers with widely disparate functional groups was generated to provide HPMA copolymers with a variety of physicochemical characteristics [24]. For hydrophilic copolymers, four different charged comonomers in two contents were employed to bestow different charge and density on the copolymers: MATC — a strong base, DEMA — a weak base, MAA — a weak acid, and SEMA — a strong acid (Scheme 1). A peptide-containing monomer, N-methacryloylglycylphenylalanylleucylglycine

Discussion

Understanding the interdependent roles that fundamental physicochemical characteristics of drug carriers play on the cellular uptake and intracellular trafficking is extremely important. For instance, one can design polymeric drug carriers with physicochemical characteristics that enable polymer–drug conjugates to be taken up efficiently or to enrich the proper membrane confined organelles, such as endosomes or lysosomes. Therefore, suitable endosomal escape or lysosomal enzymatic cleavage can

Conclusions

Endocytic uptake of HPMA copolymers is determined by their physicochemical characteristics, such as charge and molecular weight. Positively charged copolymers were internalized into cells through adsorptive endocytosis whereas negatively charged copolymers through fluid phase endocytosis. Fast uptake was observed for positively charged copolymers whereas slow and minimal uptake for negatively charged copolymers. The uptake of copolymers was in a molecular weight dependent manner. In negatively

Acknowledgment

The research was supported in part by NIH grant CA132831 from the National Cancer Institute. C4-2 prostate cancer cells were kindly provided by Dr. Ursula Elsässer-Beile, University of Freiburg, Germany. We thank Michael Jacobsen for carefully editing the manuscript.

References (52)

  • C. Lamaze et al.

    The emergence of clathrin-independent pinocytic pathways

    Curr. Opin. Cell Biol.

    (1995)
  • B. Lemieux et al.

    Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99

    Anal. Biochem.

    (2004)
  • S.C. Richardson et al.

    The use of fluorescence microscopy to define polymer localization to the late endocytic compartments in cells that are targets for drug delivery

    J. Control. Release

    (2008)
  • R. Haag et al.

    Polymer therapeutics: concepts and applications

    Angew. Chem. Int. Ed.

    (2006)
  • L.A. McCormick et al.

    Interaction of a cationic N-(2-hydroxypropyl)methacrylamide copolymer with rat visceral yolk sac cultured in vitro and rat liver in vivo

    J. Bioact. Compat. Polym.

    (1986)
  • S. Mukherjee et al.

    Endocytosis

    Physiol. Rev.

    (1997)
  • S.D. Conner et al.

    Regulated portals of entry into the cell

    Nature

    (2003)
  • M. Kirkham et al.

    Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers

    Biochim. Biophys. Acta

    (2005)
  • S. Mayor et al.

    Pathways of clathrin-independent endocytosis

    Nat. Rev. Mol. Cell Biol.

    (2007)
  • Q. Gong et al.

    Clathrin-independent internalization and recycling

    J. Cell Mol. Med.

    (2008)
  • G.J. Praefcke et al.

    The dynamin superfamily: universal membrane tubulation and fission molecules?

    Nat. Rev. Mol. Cell Biol.

    (2004)
  • A.T. Jones

    Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides

    J. Cell Mol. Med.

    (2007)
  • M.C. Kerr et al.

    Defining macropinocytosis

    Traffic

    (2009)
  • J. Kopeček

    Soluble biomedical polymers

    Polim. Med.

    (1977)
  • P.A. Vasey et al.

    Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates, Cancer Res. Campaign Phase I/II Committee

    Clin. Cancer Res.

    (1999)
  • L.W. Seymour et al.

    Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer

    Int. J. Oncol.

    (2009)
  • Cited by (54)

    • Enhanced nuclear delivery of H1-S6A, F8A peptide by NrTP6-modified polymeric platform

      2020, International Journal of Pharmaceutics
      Citation Excerpt :

      Therefore, the superior cellular uptake of PHNGFLG over H1-NrTP6 may be due to that more involved endocytosis pathways. Similar results were observed by other groups that the involvement of multiple endocytisis pathways showed better internalization (Liu et al., 2010; Sahay et al., 2008; Seib et al., 2007). The influence of NrTP6 peptidic ligands on nucleus targeting in three tumor cell lines have investigated by flow cytometry.

    • Polymer nanomedicines

      2020, Advanced Drug Delivery Reviews
      Citation Excerpt :

      Nanomedicines can surmount the efflux pump-type of multidrug resistance [295]. They are internalized in the cells by endocytosis [198] in contrast to diffusion of free low molecular weight drugs. Internalization in membrane limited organelles avoids interaction with P-glycoprotein (Pgp), an ATP-dependent efflux pump that constricts the transport of drugs into the cytoplasm [296].

    View all citing articles on Scopus
    View full text